跳至主要内容
临床试验/NCT04163198
NCT04163198招募中不适用

Investigating Methods to Improve Secretion Clearance Using Mechanical Insufflation:Exsufflation in Patients With Neuromuscular Disease.

Guy's and St Thomas' NHS Foundation Trust2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2019年12月19日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
30
试验地点
2
主要终点
Cough peak expiratory flow (cPEF)

研究概览

简要总结

Patients with neuromuscular diseases (NMD) can suffer from a range of respiratory problems due to respiratory muscle weakness. Cough muscle weakness means secretion clearance from the airways can be problematic, a source of infection, and importantly a cause of death, in this patient group. Therefore, these patients are often supported with devices to aid clearance, such as mechanical insufflation-exsufflation (MIE). Although evidence supports the use of these devices, the optimal technique or settings on the device are not clear. Increasingly, higher pressures are used during MIE and recent work has demonstrated that there may be a physiological benefit to this. However, higher pressures increase the risk of causing lung collapse and may cause detriment to blood flow back to the heart, which is important as NMD patients frequently have concurrent heart muscle weakness. Further, recent work has demonstrated that higher pressures can cause closure of the throat, which is counter-productive in secretion clearance.

The overall aim of this study is to investigate methods to manipulate MIE to improve secretion clearance in patients with NMD. The questions it seeks to answer are:

(i) how can we maximally improve lung recruitment during inspiration, whilst maintaining patient comfort and lower pressures (ii) what is the smallest pressure difference required in expiration to achieve an improvement in cough (iii) do these proposed changes to MIE also cause throat closure (iv) what factors do patients believe contribute to their adherence to MIE therapy?

Patients with slowly progressive or stable neuromuscular diseases will be included in the study. Participation will involve two visits to the Lane Fox Respiratory Unit, each lasting approximately four hours. Patients will be recruited from specialist neuromuscular respiratory clinics by their clinical teams.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Sequential
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Stable or slowly progressive neuromuscular disease
  • Respiratory muscle weakness (FVC <60%, snip <60%, sleep disordered breathing)
  • Clinical evidence of respiratory secretions or cough peak expiratory flow <270 and history of lower respiratory tract infection
  • Documented clinical stability by supervising clinician

排除标准

  • Rapidly progressive neuromuscular disease (such as motor neuron disease)
  • Decompensated respiratory failure (pH < 7.35)
  • Pregnancy
  • Aged <18
  • Change in ventilator settings in preceding 4 weeks
  • Significant physical or psychiatric co-morbidity that would prevent compliance with trial protocol

研究组 & 干预措施

Insufflation optimisation

Experimental

Patient will receive different inspiratory time and expiratory time, and inspiratory flow at a fixed insufflation pressure. To determine how best to recruit lung.

干预措施: Insufflation (Device)

Exsufflation optimisation

Experimental

Patient will receive different expiratory pressures at a fixed inspiratory pressure (optimal determine in Arm 1). To determine minimum flow bias needed to generate cPEF

干预措施: Exsufflation (Device)

结局指标

主要结局

Cough peak expiratory flow (cPEF)

时间窗: 2 days

Change in cPEF with different modalities of MI-E

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验